According to Chugai Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.45. In 2022 the company made an earnings per share (EPS) of $1.74 an increase over its 2021 EPS that were of $1.64.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.45 | -16.9% |
2022 | $1.74 | 6.08% |
2021 | $1.64 | 33.13% |
2020 | $1.23 | 39.91% |
2019 | $0.88 | 71.81% |
2018 | $0.51 | 29.79% |
2017 | $0.39 | 29.73% |
2016 | $0.30 | -1.54% |
2015 | $0.31 | 6.35% |
2014 | $0.29 | -7.3% |
2013 | $0.31 | -8.72% |
2012 | $0.34 | 25.8% |
2011 | $0.27 | -7.85% |
2010 | $0.30 | -17.84% |
2009 | $0.36 |